These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30194687)

  • 1. Anti-TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).
    Le Baut G; Peyrin-Biroulet L; Bouguen G; Gornet JM; Stefanescu C; Amiot A; Laharie D; Altwegg R; Fumery M; Trang C; Vuitton L; Simon M; Gilletta de Saint Joseph C; Nahon S; Caillo L; Del Tedesco E; Plastaras L; Aubourg A; Pineton de Chambrun G; Seksik P; Viennot S
    Aliment Pharmacol Ther; 2018 Oct; 48(8):831-838. PubMed ID: 30194687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID.
    Amiot A; Setakhr V; Seksik P; Allez M; Treton X; De Vos M; Laharie D; Colombel JF; Abitbol V; Reimund JM; Moreau J; Veyrac M; Flourié B; Cosnes J; Lemann M; Bouhnik Y
    Am J Gastroenterol; 2014 Sep; 109(9):1443-9. PubMed ID: 25091063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world Experience of Anti-tumor Necrosis Factor Therapy for Internal Fistulas in Crohn's Disease: A Retrospective Multicenter Cohort Study.
    Kobayashi T; Hishida A; Tanaka H; Nuki Y; Bamba S; Yamada A; Fujii T; Shinzaki S; Yokoyama Y; Yoshida A; Ozeki K; Ashizuka S; Kamata N; Nanjo S; Kakimoto K; Nakamura M; Matsui A; Yamauchi R; Takahashi S; Tomizawa T; Yoshino T; Hibi T
    Inflamm Bowel Dis; 2017 Dec; 23(12):2245-2251. PubMed ID: 29084079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment.
    de Groof EJ; Sahami S; Lucas C; Ponsioen CY; Bemelman WA; Buskens CJ
    Colorectal Dis; 2016 Jul; 18(7):667-75. PubMed ID: 26921847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn's Disease.
    Bouguen G; Huguet A; Amiot A; Viennot S; Cholet F; Nachury M; Flamant M; Reimund JM; Desfourneaux V; Boureille A; Siproudhis L;
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):628-636. PubMed ID: 31128337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Perianal Fistulas in Crohn's Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial.
    Wasmann KA; de Groof EJ; Stellingwerf ME; D'Haens GR; Ponsioen CY; Gecse KB; Dijkgraaf MGW; Gerhards MF; Jansen JM; Pronk A; van Tuyl SAC; Zimmerman DDE; Bruin KF; Spinelli A; Danese S; van der Bilt JDW; Mundt MW; Bemelman WA; Buskens CJ
    J Crohns Colitis; 2020 Sep; 14(8):1049-1056. PubMed ID: 31919501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients.
    Strik AS; Löwenberg M; Buskens CJ; B Gecse K; I Ponsioen C; Bemelman WA; D'Haens GR
    Scand J Gastroenterol; 2019 Apr; 54(4):453-458. PubMed ID: 31032686
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
    Behm BW; Bickston SJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing perianal Crohn's fistula in the anti-TNFα era.
    Tozer P; Borowski DW; Gupta A; Yassin N; Phillips R; Hart A
    Tech Coloproctol; 2015 Nov; 19(11):673-8. PubMed ID: 26264168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.
    Hukkinen M; Pakarinen MP; Piekkala M; Koivusalo A; Rintala R; Kolho KL
    J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genital fistulas in female Crohn's disease patients.: clinical characteristics and response to therapy.
    de la Poza G; López-Sanroman A; Taxonera C; Marín-Jimenez I; Gisbert JP; Bermejo F; Opio V; Muriel A
    J Crohns Colitis; 2012 Apr; 6(3):276-80. PubMed ID: 22405162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials.
    Peyrin-Biroulet L; Deltenre P; de Suray N; Branche J; Sandborn WJ; Colombel JF
    Clin Gastroenterol Hepatol; 2008 Jun; 6(6):644-53. PubMed ID: 18550004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn's disease.
    Plevris N; Jenkinson PW; Arnott ID; Jones GR; Lees CW
    Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):32-37. PubMed ID: 31567638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
    Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD
    Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center.
    Bor R; Farkas K; Bálint A; Szucs M; Ábrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
    Scand J Gastroenterol; 2015 Feb; 50(2):182-7. PubMed ID: 25384713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The results of seton drainage combined with anti-TNFα therapy for anal fistula in Crohn's disease.
    Haennig A; Staumont G; Lepage B; Faure P; Alric L; Buscail L; Bournet B; Moreau J
    Colorectal Dis; 2015 Apr; 17(4):311-9. PubMed ID: 25425534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study.
    Chanchlani N; Lin S; Bewshea C; Hamilton B; Thomas A; Smith R; Roberts C; Bishara M; Nice R; Lees CW; Sebastian S; Irving PM; Russell RK; McDonald TJ; Goodhand JR; Ahmad T; Kennedy NA;
    Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):521-538. PubMed ID: 38640937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's Disease.
    Taxonera C; Barreiro-de-Acosta M; Bastida G; Martinez-Gonzalez J; Merino O; García-Sánchez V; Gisbert JP; Marín-Jiménez I; López-Serrano P; Gómez-García M; Iglesias E; Lopez-Sanroman A; Chaparro M; Saro C; Bermejo F; Pérez-Carazo L; Plaza R; Olivares D; Alba C; Mendoza JL; Fernández-Blanco I
    J Crohns Colitis; 2016 Jun; 10(6):657-62. PubMed ID: 26786982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Necrosis Factor Inhibitors May Have Limited Efficacy for Complex Perianal Fistulas Without Luminal Crohn's Disease.
    McCurdy JD; Parlow S; Dawkins Y; Samji K; Rhee GG; Oliveira L; Macdonald B; Sabri E; Murthy S
    Dig Dis Sci; 2020 Jun; 65(6):1784-1789. PubMed ID: 31642006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn's disease].
    Bor R; Farkas K; Bálint A; Szűcs M; Abrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
    Orv Hetil; 2013 Dec; 154(49):1943-8. PubMed ID: 24292112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.